Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Glycotope GmbH logo — Improving the lives of cancer patients by enabling treatment...

Glycotope GmbH

Improving the lives of cancer patients by enabling treatment options that go beyond today’s standard of care

Founded 2001 Germany Berlin, Germany 11 employees Biotechnology

General Information

Company Name Glycotope GmbH
Founded Year 2001
Location Germany Berlin, Germany +1
Employees 11
Industries Biotechnology
Social

Get notified when Glycotope GmbH moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Glycotope GmbH

Glycotope GmbH is a biotechnology company founded in 2001 and headquartered in Germany. The company is committed to improving the lives of cancer patients by developing uniquely tumor-specific monoclonal antibodies using a proprietary technology platform. Their expertise in glycobiology and antibody development allows them to advance first-in-class antibody-based therapeutics for (immuno)-oncology. The company has discovered over 200 GlycoTargets and has several antibodies against selected targets under development. These antibodies have superior tumor-specificity and are suitable for development in various modes of action including naked antibodies, bispecifics, antibody-drug-conjugates, cellular therapies, or fusion proteins. With a clear focus on advancing cancer treatment options, Glycotope is poised to make significant contributions to the field of oncology.

Taxonomy: Monoclonal Antibodies, Cancer Treatment, Glycobiology, Immunotherapy, Biopharmaceuticals, Recombinant Protein Production, GMP Compliance, Antibody Discovery, Oncology, Contract Manufacturing, Active Biopharmaceutical Ingredients, ISO 9001 Certification, Gene Technology, Protein Production

No funding data available for Glycotope GmbH yet.

Get notified when Glycotope GmbH raises funding

Glycotope GmbH Alternatives & Competitors

Glycotope GmbH vs
Agro-Bio Antibodies
Agro-Bio Antibodies France

Our specificity, your antibodies

45 employees
Biopharma, Biotechnology
Glycotope GmbH vs
SystImmune
SystImmune United States

Located in Redmond WA, founded in 2014, Systimmune Inc. is a bio-pharmaceutical company focused on t...

142 employees
Glycotope GmbH vs
DotBio
DotBio Singapore

DotBio is focused on the development of novel immuno-oncology drugs based on humanized domain antibo...

Seed
18 employees
Biotechnology, Life Sciences

FAQ About Glycotope GmbH

Improving the lives of cancer patients by enabling treatment options that go beyond today’s standard of care
Glycotope GmbH was founded in 2001.
Glycotope GmbH is headquartered in Berlin, Germany.
Glycotope GmbH operates in the following industries: Biotechnology.
Glycotope GmbH has approximately 11 employees.
Top alternatives and competitors to Glycotope GmbH include Agro-Bio Antibodies, SystImmune, DotBio, Harbour BioMed, PineTree Therapeutics Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Glycotope GmbH and Agro-Bio Antibodies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Glycotope GmbH and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy